Capecitabine
HCRN BRE18-334
Phase 2 small_molecule terminated
Quick answer
Capecitabine for Breast Cancer is a Phase 2 program (small_molecule) at Vera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vera Therapeutics
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated